The Patent Finder

Methods of Treating Lennox-Gastaut Syndrome Using Fenfluramine

Zogenix, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 12,734,137Methods of Treating Lennox-Gastaut Syndrome Using Fenfluramine
In force
 · Medium confidence
Zogenix International LimitedIn forceMedium confidence
Application 15/246,346Methods of Treating Lennox-Gastaut Syndrome Using Fenfluramine
Abandoned
Abandoned Jul 6, 2020
Zogenix International LimitedAbandonedAbandoned Jul 6, 2020
Application 18/418,121Methods of Treating Lennox-Gastaut Syndrome Using Fenfluramine
Pending
Not granted
Zogenix International LimitedPendingNot granted
Application 18/418,133Methods of Treating Lennox-Gastaut Syndrome Using Fenfluramine
Pending
Not granted
Zogenix International LimitedPendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Zogenix, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited